BSX Gets One Right (BSX)

Posted in pre-market 
April 16th, 2010

Boston Scientific Corporation (NYSE: BSX) is trading higher after last night’s announcement that it will immediately resume distribution of COGNIS(R) CRT-Ds and TELIGEN(R) ICDs in the U.S.

BSX closed last night at $7.14 and the after-hours session saw a gain of 6.4% all the way up to $7.60 on a whopping 8,484,967 after-hours share volume.

At 8:30 AM EST we have seen only 233,000 shares trade hands and the stock is up 5.3% at $7.52.  The 52-week range is $6.31 to $11.77 and it trades about 35 million shares a day.


Comments are closed